Market Cap (In PLN)
223.37 Million
Revenue (In PLN)
13.2 Million
Net Income (In PLN)
-70.58 Million
Avg. Volume
2079.00
- Currency
- PLN
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 43.8-102.5
- PE
- -
- EPS
- -
- Beta Value
- 0.585
- ISIN
- PLCPTRT00014
- CUSIP
- -
- CIK
- -
- Shares
- -
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Dr. Thomas Shepherd Ph.D.
- Employee Count
- -
- Website
- https://www.captortherapeutics.com
- Ipo Date
- 2021-04-01
- Details
- Captor Therapeutics Spolka Akcyjna, a biopharmaceutical company, focuses on the discovery and development of protein degradation drugs for cancer and autoimmune diseases. The company provides Targeted Protein Degradation technology that overcomes many existing drug limitations by removing proteins resistant to available therapeutics. It has five projects at the preclinical stage. The company was incorporated in 2015 and is based in Wroclaw, Poland.
More Stocks
-
LKPSECLKP Securities Limited
LKPSEC
-
002712Simei Media Co.,Ltd.
002712
-
SWASTIKASwastika Investmart Limited
SWASTIKA
-
EGG
-
GXSBFGeox S.p.A.
GXSBF
-
HOWARHOHoward Hotels Limited
HOWARHO
-
MARISMaris Spinners Limited
MARIS
-
PRPMProTek Capital, Inc.
PRPM